Human Vaccines & Immunotherapeutics (HV&I) has entered its second decade as a well-established journal in the vaccine and immunotherapy community as well as an important forum for academics, companies, governmental and non-governmental organizations in these fields. Our journal contains a mix of high-quality original research and solicited content including timely reviews, commentaries, news, portraits, and much more. Its unique and exclusive focus on vaccines and immunotherapeutics for human use coupled with the rapid and efficient editorial processing of submitted papers has allowed HV&I to continuously increase its content and progressively improve its standing relative to other journals in the field.
Obviously, the successful development of HV&I would not have been possible without the many scientists and editors who have served as peer reviewers for HV&I. We want to take this opportunity to thank all our reviewers for their time and commitment. All peer reviewers of 2014 are listed below.
In particular, we are very pleased to recognize Dr. Simonetta Viviani (Scientific Advisor for Vaccines, Epidemiology & Public Health) as Top Reviewer 2014 for Human Vaccines & Immunotherapeutics. On behalf of the Taylor & Francis Group, we want to thank her for her commitment.
Previous Awardees were Drs. Brian Greenwood (London School of Hygiene and Tropical Medicine, UK), Brian Ward (McGill University, Montreal, Canada), James Tartaglia (Sanofi-Pasteur, Toronto, Canada), Joel Bozue (USAMRIID Bacteriology, Fort Detrick, MD, USA), Mark Kane (Consultant, Mercer Island, Seattle, WA, USA), Arístides Aguilar Betancourt (Centre for Genetic Engineering & Biotechnology, Biomedical Research Branch, Vaccines Division, Havana, Cuba), John Schiller (National Cancer Institute, NIH, Bethesda, MD, USA) and Mark Newman (consultant, Georgia, USA).